Japanese clinical practice guidelines for vascular anomalies 2017

Hidefumi Mimura; Sadanori Akita; Akihiro Fujino; Masatoshi Jinnin; Mine Ozaki; Keigo Osuga; Hiroki Nakaoka; Eiichi Morii; Akira Kuramochi; Yoko Aoki; Yasunori Arai; Noriko Aramaki; Masanori Inoue; Yuki Iwashina; Tadashi Iwanaka; Shigeru Ueno; Akihiro Umezawa; Michio Ozeki; Junko Ochi; Yoshiaki Kinoshita; Masakazu Kurita; Shien Seike; Nobuyuki Takakura; Masataka Takahashi; Takao Tachibana; Kumiko Chuman; Shuji Nagata; Mitsunaga Narushima; Yasunari Niimi; Shunsuke Nosaka; Taiki Nozaki; Kazuki Hashimoto; Ayato Hayashi; Satoshi Hirakawa; Atsuko Fujikawa; Yumiko Hori; Kentaro Matsuoka; Hideki Mori; Yuki Yamamoto; Shunsuke Yuzuriha; Naoaki Rikihisa; Shoji Watanabe; Shinichi Watanabe; Tatsuo Kuroda; Shunsuke Sugawara; Kosuke Ishikawa; Satoru Sasaki

doi:10.1111/ped.14077

Japanese clinical practice guidelines for vascular anomalies 2017

Hidefumi Mimura, Sadanori Akita, Akihiro Fujino, Masatoshi Jinnin, Mine Ozaki, Keigo Osuga, Hiroki Nakaoka, Eiichi Morii, Akira Kuramochi, Yoko Aoki, Yasunori Arai, Noriko Aramaki, Masanori Inoue, Yuki Iwashina, Tadashi Iwanaka, Shigeru Ueno, Akihiro Umezawa, Michio Ozeki, Junko Ochi, Yoshiaki KinoshitaMasakazu Kurita, Shien Seike, Nobuyuki Takakura, Masataka Takahashi, Takao Tachibana, Kumiko Chuman, Shuji Nagata, Mitsunaga Narushima, Yasunari Niimi, Shunsuke Nosaka, Taiki Nozaki, Kazuki Hashimoto, Ayato Hayashi, Satoshi Hirakawa, Atsuko Fujikawa, Yumiko Hori, Kentaro Matsuoka, Hideki Mori, Yuki Yamamoto, Shunsuke Yuzuriha, Naoaki Rikihisa, Shoji Watanabe, Shinichi Watanabe, Tatsuo Kuroda, Shunsuke Sugawara, Kosuke Ishikawa, Satoru Sasaki

Research output: Contribution to journal › Review article › peer-review

9 Citations (Scopus)

Abstract

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

Original language	English
Pages (from-to)	257-304
Number of pages	48
Journal	Pediatrics International
Volume	62
Issue number	3
DOIs	https://doi.org/10.1111/ped.14077
Publication status	Published - 2020 Mar 1

Keywords

clinical practice
guidelines
hemangioma
vascular anomalies
vascular malformation

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1111/ped.14077

Cite this

Mimura, H., Akita, S., Fujino, A., Jinnin, M., Ozaki, M., Osuga, K., Nakaoka, H., Morii, E., Kuramochi, A., Aoki, Y., Arai, Y., Aramaki, N., Inoue, M., Iwashina, Y., Iwanaka, T., Ueno, S., Umezawa, A., Ozeki, M., Ochi, J., ... Sasaki, S. (2020). Japanese clinical practice guidelines for vascular anomalies 2017. Pediatrics International, 62(3), 257-304. https://doi.org/10.1111/ped.14077

Mimura, H, Akita, S, Fujino, A, Jinnin, M, Ozaki, M, Osuga, K, Nakaoka, H, Morii, E, Kuramochi, A, Aoki, Y, Arai, Y, Aramaki, N , Inoue, M, Iwashina, Y, Iwanaka, T, Ueno, S, Umezawa, A, Ozeki, M, Ochi, J, Kinoshita, Y, Kurita, M, Seike, S, Takakura, N, Takahashi, M, Tachibana, T, Chuman, K, Nagata, S, Narushima, M, Niimi, Y, Nosaka, S, Nozaki, T, Hashimoto, K, Hayashi, A, Hirakawa, S, Fujikawa, A, Hori, Y, Matsuoka, K, Mori, H, Yamamoto, Y, Yuzuriha, S, Rikihisa, N, Watanabe, S, Watanabe, S, Kuroda, T, Sugawara, S, Ishikawa, K & Sasaki, S 2020, 'Japanese clinical practice guidelines for vascular anomalies 2017', Pediatrics International, vol. 62, no. 3, pp. 257-304. https://doi.org/10.1111/ped.14077

@article{be993117e1c744c894119d77ad63ead8,

title = "Japanese clinical practice guidelines for vascular anomalies 2017",

abstract = "The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.",

keywords = "clinical practice, guidelines, hemangioma, vascular anomalies, vascular malformation",

author = "Hidefumi Mimura and Sadanori Akita and Akihiro Fujino and Masatoshi Jinnin and Mine Ozaki and Keigo Osuga and Hiroki Nakaoka and Eiichi Morii and Akira Kuramochi and Yoko Aoki and Yasunori Arai and Noriko Aramaki and Masanori Inoue and Yuki Iwashina and Tadashi Iwanaka and Shigeru Ueno and Akihiro Umezawa and Michio Ozeki and Junko Ochi and Yoshiaki Kinoshita and Masakazu Kurita and Shien Seike and Nobuyuki Takakura and Masataka Takahashi and Takao Tachibana and Kumiko Chuman and Shuji Nagata and Mitsunaga Narushima and Yasunari Niimi and Shunsuke Nosaka and Taiki Nozaki and Kazuki Hashimoto and Ayato Hayashi and Satoshi Hirakawa and Atsuko Fujikawa and Yumiko Hori and Kentaro Matsuoka and Hideki Mori and Yuki Yamamoto and Shunsuke Yuzuriha and Naoaki Rikihisa and Shoji Watanabe and Shinichi Watanabe and Tatsuo Kuroda and Shunsuke Sugawara and Kosuke Ishikawa and Satoru Sasaki",

note = "Funding Information: The funding for preparation of the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 was from Health, Labour and Welfare Sciences Research Grants (Research on Policy Planning and Evaluation for Rare and Intractable Diseases) provided to {\textquoteleft}Japanese Research Committees for Intractable Vascular Anomalies{\textquoteright} (main funding source), {\textquoteleft}Japanese Study Group for Intractable Diseases of Pediatric Gastrointestinal Tract{\textquoteright}, and {\textquoteleft}Japanese Research Committees for Survey and Establishment of Guidelines for Pediatric Respiratory Dysplastic/hypoplastic Disease{\textquoteright}. No financial support was received from any other organization or corporation. We thank all members of the systematic review team as follows. Tomoko Izaki, Ryohei Ishiura, Yohei Iwata, Tatsuo Ueda, Naoki Okura, Sachiyo Osawa, Jun Otaka, Kuniaki Ohara, Shinya Ogishima, Takuro Kazama, Motoi Kato, Takahide Kaneko, Motohiro Kano, Tamihiro Kawakami, Tatsuki Kono, Eisuke Shibata, Yohsuke Suyama, Kazuhiro Takahashi, Yuichi Takama, Takaya Takeguchi, Kensuke Tashiro, Masashi Tamura, Atsushi Tamura, Masato Tsuchiya, Kyoichi Deie, Toshihide Tokuda, Asami Tozawa, Fumio Nagai, Michiko Nagahama, Yasuhiro Nakamura, Akifumi Nozawa, Naoki Hashizume, Takuya Hara, Koji Higuchi, Masahito Hibi, Takaya Fukumoto, Shinji Fujizuka, Megumi Furuya, Seiji Houbara, Kyoko Hoshino, Tomohiro Hori, Takanobu Maekawa, Junko Miyata, Kenji Murakami, Kiichiro Yaguchi, Daisuke Yasui, Kentaro Yamada, Yohei Yamada, Yuki Yamamoto, and Azusa Watanabe. Publisher Copyright: This article has been co-published with the permission of The Journal of Dermatology, Pediatrics International and Japanese Journal of Radiology. All rights reserved. {\textcopyright} 2020 The Authors.",

year = "2020",

month = mar,

day = "1",

doi = "10.1111/ped.14077",

language = "English",

volume = "62",

pages = "257--304",

journal = "Pediatrics International",

issn = "1328-8067",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Japanese clinical practice guidelines for vascular anomalies 2017

AU - Mimura, Hidefumi

AU - Akita, Sadanori

AU - Fujino, Akihiro

AU - Jinnin, Masatoshi

AU - Ozaki, Mine

AU - Osuga, Keigo

AU - Nakaoka, Hiroki

AU - Morii, Eiichi

AU - Kuramochi, Akira

AU - Aoki, Yoko

AU - Arai, Yasunori

AU - Aramaki, Noriko

AU - Inoue, Masanori

AU - Iwashina, Yuki

AU - Iwanaka, Tadashi

AU - Ueno, Shigeru

AU - Umezawa, Akihiro

AU - Ozeki, Michio

AU - Ochi, Junko

AU - Kinoshita, Yoshiaki

AU - Kurita, Masakazu

AU - Seike, Shien

AU - Takakura, Nobuyuki

AU - Takahashi, Masataka

AU - Tachibana, Takao

AU - Chuman, Kumiko

AU - Nagata, Shuji

AU - Narushima, Mitsunaga

AU - Niimi, Yasunari

AU - Nosaka, Shunsuke

AU - Nozaki, Taiki

AU - Hashimoto, Kazuki

AU - Hayashi, Ayato

AU - Hirakawa, Satoshi

AU - Fujikawa, Atsuko

AU - Hori, Yumiko

AU - Matsuoka, Kentaro

AU - Mori, Hideki

AU - Yamamoto, Yuki

AU - Yuzuriha, Shunsuke

AU - Rikihisa, Naoaki

AU - Watanabe, Shoji

AU - Watanabe, Shinichi

AU - Kuroda, Tatsuo

AU - Sugawara, Shunsuke

AU - Ishikawa, Kosuke

AU - Sasaki, Satoru

N1 - Funding Information: The funding for preparation of the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 was from Health, Labour and Welfare Sciences Research Grants (Research on Policy Planning and Evaluation for Rare and Intractable Diseases) provided to ‘Japanese Research Committees for Intractable Vascular Anomalies’ (main funding source), ‘Japanese Study Group for Intractable Diseases of Pediatric Gastrointestinal Tract’, and ‘Japanese Research Committees for Survey and Establishment of Guidelines for Pediatric Respiratory Dysplastic/hypoplastic Disease’. No financial support was received from any other organization or corporation. We thank all members of the systematic review team as follows. Tomoko Izaki, Ryohei Ishiura, Yohei Iwata, Tatsuo Ueda, Naoki Okura, Sachiyo Osawa, Jun Otaka, Kuniaki Ohara, Shinya Ogishima, Takuro Kazama, Motoi Kato, Takahide Kaneko, Motohiro Kano, Tamihiro Kawakami, Tatsuki Kono, Eisuke Shibata, Yohsuke Suyama, Kazuhiro Takahashi, Yuichi Takama, Takaya Takeguchi, Kensuke Tashiro, Masashi Tamura, Atsushi Tamura, Masato Tsuchiya, Kyoichi Deie, Toshihide Tokuda, Asami Tozawa, Fumio Nagai, Michiko Nagahama, Yasuhiro Nakamura, Akifumi Nozawa, Naoki Hashizume, Takuya Hara, Koji Higuchi, Masahito Hibi, Takaya Fukumoto, Shinji Fujizuka, Megumi Furuya, Seiji Houbara, Kyoko Hoshino, Tomohiro Hori, Takanobu Maekawa, Junko Miyata, Kenji Murakami, Kiichiro Yaguchi, Daisuke Yasui, Kentaro Yamada, Yohei Yamada, Yuki Yamamoto, and Azusa Watanabe. Publisher Copyright: This article has been co-published with the permission of The Journal of Dermatology, Pediatrics International and Japanese Journal of Radiology. All rights reserved. © 2020 The Authors.

PY - 2020/3/1

Y1 - 2020/3/1

N2 - The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

AB - The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

KW - clinical practice

KW - guidelines

KW - hemangioma

KW - vascular anomalies

KW - vascular malformation

UR - http://www.scopus.com/inward/record.url?scp=85082659615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082659615&partnerID=8YFLogxK

U2 - 10.1111/ped.14077

DO - 10.1111/ped.14077

M3 - Review article

C2 - 32202048

AN - SCOPUS:85082659615

SN - 1328-8067

VL - 62

SP - 257

EP - 304

JO - Pediatrics International

JF - Pediatrics International

IS - 3

ER -

Japanese clinical practice guidelines for vascular anomalies 2017

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this